The following biotech stocks featured on our website reached new highs on Friday (Dec.8, 2023). Were these stocks part of your investment portfolio?
*Last Closing Price refers to the closing price of the stock on Dec.8, 2023.
Ticker
Published Date
Published Price
Maximum Price Since Publication
*Last Closing Price
Maximum Gain %
Scholar Rock Holding Corp. (SRRK)
Sep.27, 2023
$6.76
$19.52
$18.25
188%
ALX Oncology Holdings Inc. (ALXO)
Sep.18, 2023
$5.24
$13.50
$12.26
157%
Applied Therapeutics Inc. (APLT)
May 8, 2023
$1.66
$3.36
$3.11
102%
Disc Medicine, Inc. (IRON)
Jan.23, 2023
$21.30
$63.25
$61.01
196%
CVRx, Inc. (CVRX)
Jan.30, 2023
$14.87
$24.81
$24.15
66%
Innoviva Inc. (INVA)
Apr.19, 2023
$11.34
$15.14
$15.12
33%
RxSight, Inc. (RXST)
Jul.10, 2023
$31.30
$35.04
$34.97
12%
Alpine Immune Sciences, Inc. (ALPN)
Mar.3, 2023
$7.97
$17.25
$16.84
116%
Intensity Therapeutics, Inc. (INTS)
Dec.7, 2023
$3.35
$11.44
$6.88
241%
Jin Medical International Ltd. (ZJYL)
Sep.25, 2023
$17.95
$30.45
$27.50
69%
Savara Inc. (SVRA)
June 2, 2023
$2.93
$4.26
$4.16
45%
Medpace Holdings, Inc. (MEDP)
Apr.25, 2023
$225
$289.14
$283.19
28%
Augmedix, Inc. (AUGX)
$3.65
$6.00
$5.97
64%
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.